Original Article
Evaluating the effects of empagliflozin in preventing myocardial injury in patients undergoing percutaneous coronary intervention: A double-blind, randomized clinical trial
Hossein Behzad 1 , Sina Mashayekhi 2, Hila Asham 1, Parvin Sarbakhsh 3, Taher Entezari-Maleki 1,2 *